Single-centre experience of stereotactic radiosurgery and fractionated stereotactic radiotherapy for prolactinomas with the linear accelerator

Journal of Medical Imaging and Radiation Oncology

Volumn 59, Issue 3, 2015, Pages 371-378

  Wilson, Peter J ^a,b   Williams, Janet Rosemary ^a   Smee, Robert Ian ^a,b  

^a The Prince of Wales Cancer Centre   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

endocrine therapy; fractionated radiotherapy; linear accelerator; prolactinoma; stereotactic radiosurgery

Indexed keywords

BROMOCRIPTINE; CABERGOLINE; PROLACTIN; BIOLOGICAL MARKER;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER REGRESSION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; FOLLOW UP; FRACTIONATED STEREOTACTIC RADIOTHERAPY; HISTOPATHOLOGY; HUMAN; LINEAR ACCELERATOR; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SAFETY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROLACTINOMA; STEREOTACTIC RADIOSURGERY; TEMPORAL LOBE EPILEPSY; TUMOR VOLUME; BLOOD; COMPARATIVE STUDY; MIDDLE AGED; NEW SOUTH WALES; PITUITARY NEOPLASMS; RADIATION DOSE FRACTIONATION; RADIOSURGERY; REPRODUCIBILITY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; AGED; BIOMARKERS; DOSE FRACTIONATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEW SOUTH WALES; PITUITARY NEOPLASMS; PROLACTIN; PROLACTINOMA; RADIOSURGERY; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84930434925     PISSN: 17549477     EISSN: 17549485     Source Type: Journal    
DOI: 10.1111/1754-9485.12257     Document Type: Article

References (29)

1. Colao A,. Pituitary tumours: the prolactinoma. Best Pract Res Clin Endocrinol Metab 2009; 23: 575-596.
2. Mindermann T, Wilson CB,. Age-related and gender-related occurrence of pituitary adenomas. Clin Endocrinol (Oxf) 1994; 41: 359-364.
3. Klibanski A,. Clinical practice. Prolactinomas. N Engl J Med 2010; 362: 1219-1226.
4. Molitch ME,. Medical management of prolactin-secreting pituitary adenomas. Pituitary 2002; 5: 55-65.
5. Colao A, Di Sarno A, Cappabianca P, Di Somma C, Pivonello R, Lombardi G,. Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia. N Engl J Med 2003; 349: 2023-2033.
6. Barber TM, Kenkre J, Garnett C, Scott RV, Byrne JV, Wass JA,. Recurrence of hyperprolactinaemia following discontinuation of dopamine agonist therapy in patients with prolactinoma occurs commonly especially in macroprolactinoma. Clin Endocrinol (Oxf) 2011; 75: 819-824.
7. Gökalp HZ, Deda H, Attar A, Uʇur HC, Arasil E, Egemen N,. The neurosurgical management of prolactinomas. J Neurosurg Sci 2000; 44: 128-132.
8. Sheplan Olsen LJ, Robles Irizarry L, Chao ST, Weil RJ, Hamrahian AH, Hatipoglu B, et al. Radiotherapy for prolactin-secreting pituitary tumors. Pituitary 2012; 15: 135-145.
9. Vilar L, Freitas MC, Naves LA, Casulari LA, Azevedo M, Montenegro R Jr, et al. Diagnosis and management of hyperprolactinemia: results of a Brazilian multicenter study with 1234 patients. J Endocrinol Invest 2008; 31: 436-444.
10. Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 273-288.
11. Liu JK, Couldwell WT,. Contemporary management of prolactinomas. Neurosurg Focus 2004; 16: E2.
12. Tyrrell JB, Lamborn KR, Hannegan LT, Applebury CB, Wilson CB,. Transsphenoidal microsurgical therapy of prolactinomas: initial outcomes and long-term results. Neurosurgery 1999; 44: 254-261, discussion 261-263.
13. Roelfsema F, Biermasz NR, Pereira AM,. Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis. Pituitary 2012; 15: 71-83.
14. Gillam MP, Molitch ME, Lombardi G, Colao A,. Advances in the treatment of prolactinomas. Endocr Rev 2006; 27: 485-534.
15. Yoon SC, Suh TS, Jang HS, Chung SM, Kim YS, Ryu MR, et al. Clinical results of 24 pituitary macroadenomas with linac-based stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 1998; 41: 849-853.
16. Voges J, Kocher M, Runge M, Poggenborg J, Lehrke R, Lenartz D, et al. Linear accelerator radiosurgery for pituitary macroadenomas: a 7-year follow-up study. Cancer 2006; 107: 1355-1364.
17. Pollock BE, Brown PD, Nippoldt TB, Young WF Jr,. Pituitary tumor type affects the chance of biochemical remission after radiosurgery of hormone-secreting pituitary adenomas. Neurosurgery 2008; 62: 1271-1276, discussion 1276-1278.
18. Konnov BA, Lebedeva NA, Pushkareva TV,. Results of proton therapy in the treatment of pituitary prolactin-secreting adenomas. Vestn Rentgenol Radiol 1993; 5: 46-49.
19. Kajiwara K, Saito K, Yoshikawa K, Kato S, Akimura T, Nomura S, et al. Image-guided stereotactic radiosurgery with the CyberKnife for pituitary adenomas. Minim Invasive Neurosurg 2005; 48: 91-96.
20. Liu X, Kano H, Kondziolka D, Park K-J, Iyer A, Shin S, et al. Gamma knife stereotactic radiosurgery for drug resistant or intolerant invasive prolactinomas. Pituitary 2012; 16: 68-75.
21. Sheehan JP, Pouratian N, Steiner L, Laws ER, Vance ML,. Gamma knife surgery for pituitary adenomas: factors related to radiological and endocrine outcomes. J Neurosurg 2011; 114: 303-309.
22. Landolt AM, Lomax N,. Gamma knife radiosurgery for prolactinomas. J Neurosurg 2000; 93 (Suppl. 3): 14-18.
23. Pouratian N, Sheehan J, Jagannathan J, Laws ER Jr, Steiner L, Vance ML,. Gamma knife radiosurgery for medically and surgically refractory prolactinomas. Neurosurgery 2006; 59: 255-266, discussion 255-266.
24. Castinetti F, Nagai M, Morange I, Dufour H, Caron P, Chanson P, et al. Long-term results of stereotactic radiosurgery in secretory pituitary adenomas. J Clin Endocrinol Metab 2009; 94: 3400-3407.
25. Pamir MN, Kiliç T, Belirgen M, Abacioʇlu U, Karabekiroʇlu N,. Pituitary adenomas treated with gamma knife radiosurgery: volumetric analysis of 100 cases with minimum 3 year follow-up. Neurosurgery 2007; 61: 270-280, discussion 280.
26. Schlechte J, Dolan K, Sherman B, Chapler F, Luciano A,. The natural history of untreated hyperprolactinemia: a prospective analysis. J Clin Endocrinol Metab 1989; 68: 412-418.
27. Sisam DA, Sheehan JP, Sheeler LR,. The natural history of untreated microprolactinomas. Fertil Steril 1987; 48: 67-71.
28. Weiss MH, Teal J, Gott P, Wycoff R, Yadley R, Apuzzo ML, et al. Natural history of microprolactinomas: six-year follow-up. Neurosurgery 1983; 12: 180-183.
29. Castro DG, Cecílio SAJ, Canteras MM,. Radiosurgery for pituitary adenomas: evaluation of its efficacy and safety. Radiat Oncol 2010; 5: 109.